1888PressRelease.com
1888 PressRelease Home Sign In Register About Us Sitemap
  
31
Oct
2009

Tompkins Pharmaceutical Rubber Acquires Operating Assets of Amerimold Tech Inc.

Tompkins Pharmaceutical Rubber Corporation, a NJ manufacturer of custom molded rubber products for the pharmaceutical and medical industries, has purchased the operating assets of Amerimold Tech, Inc. of Marlboro, NJ.


(1888PressRelease) October 31, 2009 - Tompkins Pharmaceutical Rubber Corporation, a NJ manufacturer of custom molded rubber products for the pharmaceutical and medical industries, has purchased the operating assets of Amerimold Tech, Inc. of Marlboro, NJ. A fixture in the custom molding business for more than 60 years, the Amerimold acquisition has expanded Tompkins molding capabilities, particularly in the areas of Liquid Injection Silicone Molding.

“Tompkins and Amerimold Tech collectively have more than 165 years experience in the pharmaceutical and medical products industries,” states Michael Carollo, Tompkins Division President. “Our expertise and tools are geared for the precise manufacturing and rigors of drug and medical product packaging.”

Tompkins is a certified ISO 9000:20001 component manufacturer, with separate molding operations and the use of DI water for cleaning pharmaceutical and medical device products. The firm maintains a full-time engineering staff, on site quality control laboratory and in house tool and die shop.

In addition to Amerimold Tech’s specialty equipment, Amerimold’s staff, including President Michael Schon are now Tompkins employees. “Amerimold’s key personnel are experienced injection molding professionals. They have molded miniscule

###
 

Other Related Press Releases

InterDyn - CFO Consulting Hires David Henderson as Account Executive by Interdyn - Cfo Consulting

Tompkins Pharmaceutical Rubber Acquires Operating Assets of Amerimold Tech Inc. by Eli Minatore

NAFA Salutes Paul Condran and The City Of Culver For Their Outstanding Environmental Efforts by Nafa

Contact Information

Adam

Eli Minatore

Visit our Site

Press Release Tools